Login to Your Account

Poly-pharmacy Still Rules

Hope '4-A' Break in Asthma; FLAP Made Over New Bids

By Randy Osborne

Monday, March 29, 2010
Spring's onset brings pollen, allergies and - for many - asthma, which for as much as 35 percent of patients falls into the category of "uncontrolled." That's the high end of the estimated subset of about 22 million adult asthmatics in the U.S., and about the same number overseas. Corticosteroids aren't getting the job done, but which new target can, in a crowded market worth about $12.7 billion worldwide, according to GlobalData?

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription